Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    kanchan joshi joshi
    kanchan joshi joshi
      • Home
      • kanchan joshi joshi

      Articles By : kanchan joshi joshi

      Ex-Ranbaxy promoters to submit asset declarations to Delhi HC in Daiichi Case

      Ex-Ranbaxy promoters to submit asset declarations to Delhi HC in Daiichi Case

      kanchan joshi joshi1 Dec 2016 1:34 PM IST
      Arguments to be heard in March 2017New Delhi: Hearing on the case of enforcement of Singapore arbitration award on Singh brothers on Monday, the High...
      Government to notify list of Over-the-counter drugs

      Government to notify list of Over-the-counter drugs

      kanchan joshi joshi30 Nov 2016 1:26 PM IST
      New Delhi: In an initiative to stop the sale of antibiotics and other high-risk drugs without prescription by some pharmacies, as well as to ease out...
      Shocking: 27 medicines sold by 18 major drug companies fail quality control  

      Shocking: 27 medicines sold by 18 major drug companies fail quality control  

      kanchan joshi joshi29 Nov 2016 5:51 PM IST
      New Delhi: In a major crackdown, 27 commonly sold medicines, which are formulated and labelled under 18 major pharmaceutical brands of India have seem...
      Maharshtra: Orbimed plans to invest 40 million dollars in Suraksha Diagnostics

      Maharshtra: Orbimed plans to invest 40 million dollars in Suraksha Diagnostics

      kanchan joshi joshi20 Nov 2016 2:59 PM IST
      Mumbai: After investing in Marquee healthcare, Orbimed, renowned healthcare industry investor, is now expected to invest in Kolkata-based Suraksha...
      Tamil Nadu: Insurance Company to pay compensation for denying mediclaim

      Tamil Nadu: Insurance Company to pay compensation for denying mediclaim

      kanchan joshi joshi17 Nov 2016 5:18 PM IST
      Srivilliputtur: In a case filed by one V.K. Beemaraja against the Oriental Insurance Company for non-payment of his mediclaim, Virudhunagar District...
      Government writes to DoP to repeal three pharmaceuticals Acts

      Government writes to DoP to repeal three pharmaceuticals Acts

      kanchan joshi joshi15 Nov 2016 2:59 PM IST
      New Delhi: Three Acts governing the pharmacetuical industry, in all likelihood are expected to be repealed, as the government has written to the...
      Supreme Court : NPPA to recover more than Rs 1,000 Crore from drug makers

      Supreme Court : NPPA to recover more than Rs 1,000 Crore from drug makers

      kanchan joshi joshi11 Nov 2016 2:42 PM IST
      New Delhi: National Pharmaceutical Pricing Authority has initiated a move to recover an amount of more than Rs. 1,000 crore from drug makers allegedly...
      National Pharmaceutical Pricing Authority likely to be disbanded soon

      National Pharmaceutical Pricing Authority likely to be disbanded soon

      kanchan joshi joshi5 Nov 2016 11:06 AM IST
      New Delhi: Addressing the concerns regarding excessive control by the authority while obstructing innovation and competitiveness, the union Health...
      New diabetic drugs to cost less

      New diabetic drugs to cost less

      kanchan joshi joshi31 Oct 2016 9:54 AM IST
      Delhi: A new class of diabetes drugs are indeed bringing a sense of relief to the Indian Diabetics. While on one hand these drugs are an advancement...
      PMO says no to China  Active Pharmaceutical Ingredient imports

      PMO says no to China Active Pharmaceutical Ingredient imports

      kanchan joshi joshi27 Oct 2016 5:34 PM IST
      New Delhi: China has the biggest market in India for its exports, akin to its other markets now the pharmaceutical export trade has come under budge...
      Lanxess India upgrade facilities in Nagda Civil Hospital

      Lanxess India upgrade facilities in Nagda Civil Hospital

      kanchan joshi joshi26 Oct 2016 11:11 AM IST
      Nagda: The German speciality chemicals firm, Lanxes India has signed a three-year long contract with a civil hospital in the district as a part of its...
      Supreme Court judgement blows Cipla for overpricing, slaps Rs 1700 cr fine

      Supreme Court judgement blows Cipla for overpricing, slaps Rs 1700 cr fine

      kanchan joshi joshi22 Oct 2016 4:25 PM IST
      Mumbai: In a blow to Mumbai based pharma giant CIPLA, the Supreme Court has upheld the government's stand to penalize the company under Drug (Price...
      Next

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok